-
Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed)
(PAR-23-276)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)
(PAR-23-277)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed)
(PAR-23-278)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
(PAR-23-301)
National Human Genome Research Institute
Application Receipt Date(s): January 7, 2027
-
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
(PAR-23-302)
National Human Genome Research Institute
Application Receipt Date(s): January 7, 2027
-
Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional)
(PAR-23-309)
National Institute on Minority Health and Health Disparities
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Cancer Institute
National Institute on Deafness and Other Communication Disorders
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute of Nursing Research
National Institute of Neurological Disorders and Stroke
National Institute of Biomedical Imaging and Bioengineering
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): November 5, 2026
-
Fc-Dependent Mechanisms of Antibody-Mediated Killing (R01 Clinical Trial Not Allowed)
(RFA-AI-23-054)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): January 26, 2024
-
Mechanistic Studies of the Effects of Psychosocial Stress on Complex Morbidity Involving SUD, Psychiatric Disorders, and HIV (R01 Clinical Trials Optional)
(RFA-DA-24-005)
National Institute on Drug Abuse
Application Receipt Date(s): February 15, 2024
-
Mechanistic Studies of the Effects of Psychosocial Stress on Complex Morbidity Involving SUD, Psychiatric Disorders, and HIV (R01 Basic Experimental Studies with Humans (BESH) Required)
(RFA-DA-24-006)
National Institute on Drug Abuse
Application Receipt Date(s): February 15, 2024
-
Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Clinical Trial Optional)
(RFA-DA-24-031)
National Institute on Drug Abuse
Application Receipt Date(s): August 14, 2026
-
Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Basic Experimental Studies with Humans Required)
(RFA-DA-24-032)
National Institute on Drug Abuse
Application Receipt Date(s): August 14, 2026
-
Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Clinical Trial Optional)
(RFA-DA-24-033)
National Institute on Drug Abuse
Application Receipt Date(s): August 14, 2026
-
Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)
(RFA-DA-25-047)
National Institute on Drug Abuse
Application Receipt Date(s): March 13, 2026
-
Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)
(RFA-DA-25-048)
National Institute on Drug Abuse
Application Receipt Date(s): March 13, 2026
-
NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed)
(RFA-DE-24-006)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): February 13, 2024
-
Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 - Clinical Trial Required)
(RFA-MD-24-003)
National Institute on Minority Health and Health Disparities
National Heart, Lung, and Blood Institute
Office of Research on Women's Health
Application Receipt Date(s): Multiple dates, see announcement.
-
Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)
(RFA-NS-23-032)
National Institute of Neurological Disorders and Stroke
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): November 28, 2023